IL217722B - Prethyroid hormone (34-1 pth) for use in the prevention and/or treatment of worsening osteoarthritis of the knee accompanying osteoporosis - Google Patents

Prethyroid hormone (34-1 pth) for use in the prevention and/or treatment of worsening osteoarthritis of the knee accompanying osteoporosis

Info

Publication number
IL217722B
IL217722B IL217722A IL21772212A IL217722B IL 217722 B IL217722 B IL 217722B IL 217722 A IL217722 A IL 217722A IL 21772212 A IL21772212 A IL 21772212A IL 217722 B IL217722 B IL 217722B
Authority
IL
Israel
Prior art keywords
osteoporosis
concomitant
treating
preventing
parathyroid hormone
Prior art date
Application number
IL217722A
Other languages
English (en)
Hebrew (he)
Other versions
IL217722A0 (en
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of IL217722A0 publication Critical patent/IL217722A0/en
Publication of IL217722B publication Critical patent/IL217722B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL217722A 2009-11-18 2012-01-25 Prethyroid hormone (34-1 pth) for use in the prevention and/or treatment of worsening osteoarthritis of the knee accompanying osteoporosis IL217722B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26221409P 2009-11-18 2009-11-18
PCT/JP2010/069742 WO2011062073A1 (ja) 2009-11-18 2010-11-05 ヒト変形性膝関節症の予防剤および／または治療剤および／または増悪抑制剤

Publications (2)

Publication Number Publication Date
IL217722A0 IL217722A0 (en) 2012-03-29
IL217722B true IL217722B (en) 2018-06-28

Family

ID=44059554

Family Applications (1)

Application Number Title Priority Date Filing Date
IL217722A IL217722B (en) 2009-11-18 2012-01-25 Prethyroid hormone (34-1 pth) for use in the prevention and/or treatment of worsening osteoarthritis of the knee accompanying osteoporosis

Country Status (14)

Country Link
US (2) US20110172154A1 (xx)
EP (1) EP2502632B1 (xx)
JP (1) JP5969763B2 (xx)
KR (1) KR101686271B1 (xx)
CN (1) CN102686236A (xx)
AU (1) AU2010320272B2 (xx)
BR (1) BR112012002391A2 (xx)
CA (1) CA2770340C (xx)
ES (1) ES2616004T3 (xx)
IL (1) IL217722B (xx)
MX (1) MX339484B (xx)
NZ (1) NZ598856A (xx)
RU (1) RU2569754C2 (xx)
WO (1) WO2011062073A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107635576A (zh) * 2015-07-07 2018-01-26 旭化成制药株式会社 特发性股骨头坏死症的发病预防和/或进展抑制剂
JP7010934B2 (ja) * 2016-06-10 2022-02-10 レギュラキス 変形性関節症の治療のためのペプチド
JP2020506926A (ja) * 2017-02-01 2020-03-05 ザ・ジョンズ・ホプキンス・ユニバーシティ 副甲状腺ホルモンと変性椎間板疾患の再生

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140924A (en) 1980-04-04 1981-11-04 Teijin Ltd Calcitonin pharmaceutical preparation
GB2092002B (en) 1981-01-14 1985-09-11 Toyo Jozo Kk Suppositories injectable solutions
CA1188987A (en) 1981-03-06 1985-06-18 Masataka Morishita Preparation having excellent absorption property
JPS60161924A (ja) 1984-02-01 1985-08-23 Fujisawa Pharmaceut Co Ltd 肺吸収用組成物
JPS63243033A (ja) 1987-03-31 1988-10-07 Toyo Jozo Co Ltd 経鼻投与組成物
JPS63316737A (ja) 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
JP2505812B2 (ja) 1987-07-10 1996-06-12 旭化成工業株式会社 ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
JPH02111A (ja) 1987-08-03 1990-01-05 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド製剤
JPH01230530A (ja) 1987-11-21 1989-09-14 Toyo Jozo Co Ltd カルシトニン類経鼻投与用液剤組成物
JPH02104531A (ja) 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
JPH07238033A (ja) 1993-10-27 1995-09-12 Chugai Pharmaceut Co Ltd 軟骨整復術治療促進剤
JP2006137768A (ja) 1993-10-27 2006-06-01 Chugai Pharmaceut Co Ltd 軟骨整復術治療促進剤
JP3901761B2 (ja) 1995-02-20 2007-04-04 幸夫 加藤 変形性関節症および炎症性関節疾患治療剤
US6787518B1 (en) * 1995-02-20 2004-09-07 Yukio Kato Therapeutics of osteoarthritis and inflammatory joint disease
TWI293563B (en) 2000-06-30 2008-02-21 Asubio Pharma Co Ltd Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
WO2004067021A1 (en) * 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
JPWO2005102381A1 (ja) * 2004-04-26 2008-03-06 小野薬品工業株式会社 カテプシンｋ阻害薬およびｐｔｈ類を併用することを特徴とする骨密度増加剤
JP2006143603A (ja) * 2004-11-16 2006-06-08 Asahi Kasei Pharma Kk 骨疾患治療用医薬複合剤
US20090010940A1 (en) * 2005-09-06 2009-01-08 Paul Morley Parathyroid Hormone Analogues and Methods of Use
WO2010045229A2 (en) * 2008-10-13 2010-04-22 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
US8586533B2 (en) * 2008-12-16 2013-11-19 Kaohsiung Medical University Treatment of early-stage osteoarthritis
US8530420B2 (en) * 2008-12-16 2013-09-10 Kaohsiung Medical University Treatment of arthritis with parathyroid hormone
KR102424644B1 (ko) * 2009-09-09 2022-07-25 아사히 가세이 파마 가부시키가이샤 1회당 100∼200 단위의 ｐｔｈ가 주 1회 투여되는 것을 특징으로 하는, ｐｔｈ 함유 골다공증 치료/예방제

Also Published As

Publication number Publication date
AU2010320272B2 (en) 2015-01-22
JPWO2011062073A1 (ja) 2013-04-04
CA2770340C (en) 2019-08-27
ES2616004T3 (es) 2017-06-09
EP2502632A1 (en) 2012-09-26
IL217722A0 (en) 2012-03-29
BR112012002391A2 (pt) 2016-06-07
NZ598856A (en) 2013-10-25
EP2502632A4 (en) 2013-04-03
MX339484B (es) 2016-05-27
MX2012003892A (es) 2012-05-08
CA2770340A1 (en) 2011-05-26
RU2569754C2 (ru) 2015-11-27
AU2010320272A1 (en) 2012-04-12
KR20120116901A (ko) 2012-10-23
EP2502632B1 (en) 2016-12-28
CN102686236A (zh) 2012-09-19
RU2012125066A (ru) 2013-12-27
WO2011062073A1 (ja) 2011-05-26
JP5969763B2 (ja) 2016-08-17
US20130012440A1 (en) 2013-01-10
KR101686271B1 (ko) 2016-12-13
US20110172154A1 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
HUS1700008I1 (hu) Terápiás szerek a mellékpajzsmirigy-hormon szintjének csökkentésére
EP2222240A4 (en) DEVICE AND METHOD FOR ATTACHING AN ORTHOPEDIC FRACTURE
IL214105A (en) Screw for bone comprising composite materials
EP2364128A4 (en) SYSTEM FOR USE IN THE TREATMENT OF SPINE FRACTURES
EP2509520A4 (en) METHOD AND DEVICE FOR TREATING SPINE FRACTURES
EP2558009A4 (en) INTRAMEDULLARY FIXING DEVICE AND METHOD FOR BONE FIXING AND STABILIZATION
EP2453809A4 (en) METHOD AND DEVICE FOR TREATING A HIP JOINT, AND PROVIDING AND USING A NOVEL SEAM TRANSITION THEREFOR
EP2114322A4 (en) ORTHOPEDIC CLAMPS AND COMPONENTS FOR USE THEREIN
EP2819620A4 (en) METHOD AND APPARATUS FOR TREATING BONE FRACTURES, INCLUDING THE USE OF COMPOSITE IMPLANTS
IL210763A0 (en) Device and method to prevent hip fractures
EP2402041A4 (en) BONE CEMENT COMPOSITION, KIT FOR BONE CEMENT COMPOSITION AND METHOD FOR THE PRODUCTION OF A BONE CEMENT HARDENING BODY
IL207532A0 (en) Glp-1 receptor agonists and related phamaceutical ingredients for the treatment of cancer
EP2411038A4 (en) PARATHYOIDHORMONEPEPTIDES AND PARATHYROIDHORMONE-RELATED PROTEINPEPTIDES AND METHOD OF USE THEREOF
EP2505176A4 (en) DEVICE FOR INCREASING HUMAN HEALTH CAPACITY AND METHOD FOR OPERATING THE DEVICE TO INCREASE HUMAN HEALTH ABILITY
EP2303160A4 (en) BONE FRACTURE TREATMENT DEVICES AND METHODS OF USE
ZA201206196B (en) Bone fracture fixation means
EP2450038A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETIC NEUROPATHY AND MANUFACTURING AND USE METHODS
HK1173949A1 (en) Glp-2 for use in the treatment of muscle atrophy glp-2
IL217722B (en) Prethyroid hormone (34-1 pth) for use in the prevention and/or treatment of worsening osteoarthritis of the knee accompanying osteoporosis
EP2413992A4 (en) METHOD AND APPARATUS FOR DISPENSING BONE CEMENT
PL2007416T3 (pl) Parathormon (PTH) do zastosowania w leczeniu niedokrwienia
EP2516628A4 (en) TREATMENT OF BONE FRACTURES
PL2480181T3 (pl) Element ustalający oraz zastosowanie takiego elementu ustalającego do ustalania obiektu w szczególności kończyn
HK1145453A1 (en) A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof
PL389129A1 (pl) Sposób wytwarzania oksysoli w dwuskładnikowym układzie molibdenianu(VI) kadmu i wolframianów(VI) metali

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed